FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 2571 - NIH Clinical Center Research Hospital Board - Authorized by Law

GENERAL INFORMATION

Committee Name	NIH Clinical Center Research Hospital Board	Agency Name	Department of Health and Human Services
Fiscal Year	2025	Committee Number	2571
Original Establishment Date	6/15/2016	Committee Status	Chartered
Actual Termination Date		Committee URL	https://ccrhb.od.nih.gov/
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	14
Terminated This FY	No	Designated Fed Officer Position Title*	Deputy Director for Intramural Research
Merged This FY		Designated Federal Officer Prefix
Current Charter Date	6/15/2024	Designated Federal Officer First Name*	Nina
Date Of Renewal Charter	6/15/2026	Designated Federal Officer Middle Name	F.
Projected Termination Date		Designated Federal Officer Last Name*	Schor
Exempt From Renewal*	No	Designated Federal Officer Suffix	MD, PHD
Specific Termination Authority		Designated Federal Officer Phone*	301.496.1921
Establishment Authority*	Authorized by Law	Designated Federal Officer Fax*
Specific Establishment Authority*	42USC282(b)(16) Section 402(b)(16)	Designated Federal Officer Email*	nina.schor@nih.gov
Effective Date Of Authority*	11/20/1985
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	Scientific Technical Program Advisory Board

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Continue
Legislation to Terminate Required	Not Applicable
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	The NIH Clinical Center Research Hospital Board (CCRHB) advises, consults with, and makes recommendations to the NIH Director and designee(s) and the NIH Clinical Center (CC) Chief Executive Officer (CEO) on CC policies and procedures regarding hospital operations, safety and quality, regulatory compliance, clinical research, and hospital leadership. The Board consists of external advisors who are national healthcare leaders, as well as stakeholders in the clinical research community. These thought leaders are passionate about their service to the CCRHB in sharing knowledge and expertise from leading institutions in healthcare across the nation. Members represent diverse clinical and scientific perspectives with significant professional and personal experience of great value to the CC, as the world’s largest hospital dedicated to clinical research.
How is membership balanced?*	The Board consists of up to 14 non-federal members. The members are nationally recognized leaders selected from the academic and private sector hospital administration/operations, clinical care, and clinical research communities, as well as the general public. Membership includes 2 patient advocates.
How frequent & relevant are cmte mtgs?*	The Board met two times during this reporting period; although the goal is to meet three times per year. The CCRHB charter notes that “The Board will meet approximately three times within a fiscal year; ” however, the February 2025 meeting was canceled in alignment with transition guidance that Federal advisory committee meetings at that time were canceled. CCRHB meetings are integral to assuring the CC continues to align itself with the current best practices and benchmarks in the community.
Why advice can't be obtained elsewhere?*	The NIH Clinical Center is the nation's premier research hospital. The Board's primary aim is to reinforce the CC’s commitment to essential patient safety while continuing to add to its long list of extraordinary scientific accomplishments to improve health. The CCRHB was created to fortify a CC culture and practice of safety and quality throughout the organization, and to assure strong leadership for clinical care quality, oversight, and compliance. These perspectives are key factors in membership selection and have allowed significant organizational priorities to be developed focused on safety and quality in CC operations and clinical care. Members are also selected to assure broad and diverse representation from the community.
Why close or partially close meetings?	There were no closed or partially closed meetings in this reporting period. The charter addresses approval measures needed if closed sessions are warranted.
Recommendation Remarks	Deliberations and discussions during all meetings are posted on the CCRHB website (https://www.ccrhb.od.nih.gov/meetings.html) and the number of recommendations is variable, dependent upon the topic discussed. Discussions always reflect candid observations, suggestions, and recommendations from Board members, but the Board did not produce any formal recommendations or generalizable public reports during this reporting period. The Committee Decision Maker and the Designated Federal Officer are filled by the same individual based on assigned duties. The committee membership is up to 14 members however CCRHB chooses to have 11 at one given time. Dr. Samitt resigned from the committee on 11/30/2024. Dr. Devaskar has been reappointed.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	Yes	Action Reorganize Priorities*	No
Outcome Trust In Government	Yes	Action Reallocate Resources	No
Outcome Major Policy Changes	Yes	Action Issued New Regulations	No
Outcome Advance In Scientific Research	No	Action Proposed Legislation	No
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	Yes	Action Other	No
Outcome Increased Customer Satisfaction	No	Action Comment	Not Applicable
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment	Not Applicable	Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	Not Applicable	Grants Review Comment	Not Applicable
Number Of Recommendations*	0	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	Discussions, deliberations, and observations during CCRHB meetings provide essential guidance to the NIH Office of the Director Leadership and the CC CEO. All recommendations, formal or informal, are considered carefully.	Access Agency Website	Yes
% of Recs Fully Implemented*	0.00%	Access Committee Website	Yes
% of Recs Fully Implemented Comment	Not Applicable	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	0.00%	Access Publications	No
% of Recs Partially Implemented Comment	Not Applicable	Access Other	No
Agency Feedback*	Yes	Access Comment	Not Applicable
Agency Feedback Comment*	Information is provided to the public at each meeting. The public can view information related to the Committee through the committee’s official website.	Narrative Description*	NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. NIH works toward that mission by: conducting research in its own laboratories; supporting the research of non-Federal scientists in universities, medical schools, hospitals, and research institutions throughout the country and abroad; helping in the training of research investigators; and fostering communication of medical and health sciences information. The NIH Clinical Center Research Hospital Board advises and consults with the NIH Director on the NIH Clinical Center's policies and procedures regarding hospital operations, safety and quality, and regulatory compliance.

COSTS

1. Payments to Non-Federal Members*	$3,600.00	1. Est Paymnts to Non-Fed Membrs Nxt FY*	$3,600.00
2. Payments to Federal Members*		2. Est. Payments to Fed Members Next FY*
3. Payments to Federal Staff*	$9,211.00	3. Estimated Payments to Federal Staff*	$9,758.00
4. Payments to Consultants*	$200.00	4. Est. Payments to Consultants Next FY*	$200.00
5. Travel Reimb. For Non-Federal Membrs*	$3,038.00	5. Est Travel Reimb Non-Fed Membr nxtFY*	$3,054.00
6. Travel Reimb. For Federal Members*		6. Est Travel Reimb For Fed Members*
7. Travel Reimb. For Federal Staff*		7. Est. Travel Reimb to Fed Staf Nxt FY*
8. Travel Reimb. For Consultants*		8. Est Travel Reimb to Consltnts Nxt FY*
10. Other Costs	$42,834.00	10. Est. Other Costs Next FY*	$43,262.00
11. Total Costs	$58,883.00	11. Est. Total Next FY*	$59,874.00
Date Cost Last Modified	9/17/2025 8:08 AM	Est. Fed Staff Support Next FY*	0.10
Federal Staff Support (FTE)*	0.10	Est Cost Remarks
Cost Remarks

Interest Areas

Category Area Health Health Care Hospitals Safety

Custom Links

Committee Level Reports